Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CCR3 | P51677 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4088688 | 0.86 | HPGD (0.46) | KMT2AMEN1SMN1; SMN2HPGDTAS1R3 | |
| SCHEMBL4086683 | 0.84 | SMN1; SMN2 (0.41) | KMT2AMEN1SMN1; SMN2HPGDTAS1R3 | |
| SCHEMBL4092763 | 0.79 | MLYCD (0.41) | KMT2AMEN1SMN1; SMN2HPGDTAS1R3 | |
| SCHEMBL9937352 | 0.76 | LMNA (0.53) | KMT2AMEN1SMN1; SMN2HPGDTDP1 | |
| SCHEMBL13505507 | 0.76 | LMNA (0.53) | KMT2AMEN1SMN1; SMN2HPGDTDP1 | |
| SCHEMBL5661430 | 0.76 | LMNA (0.41) | KMT2AMEN1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL5552111 | 0.76 | LMNA (0.41) | KMT2AMEN1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL5552114 | 0.76 | LMNA (0.41) | KMT2AMEN1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL5552121 | 0.76 | LMNA (0.41) | KMT2AMEN1SMN1; SMN2TAS1R3TAS1R1 | |
| SCHEMBL5662210 | 0.76 | KMT2A (0.44) | KMT2AMEN1SMN1; SMN2HPGDTAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023667-A1 | Composition For Preventing Harmful Organisms | MITSUI CHEMICALS, INC. (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1872658-A1 | PESTICIDAL COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-20070049635-A1 | Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients | MITSUI CHEMICALS, INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| EP-1681285-A1 | DIAMINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PLANT DISEASE CONTROL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | Mitsui Chemicals, Inc. (JP) | 2006-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049635-A1 | Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients | HRH4, HRH1, DDT | KMT2A 435/4885MEN1 1873/4885SMN1; SMN2 3370/4885 |
| US-20090023667-A1 | Composition For Preventing Harmful Organisms | DDT, CBR3, AHR | KMT2A 1247/4885MEN1 2918/4885SMN1; SMN2 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.